3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
3
Breast
2
Other neoplasm
1
Other hematologic neoplasm
1
NET
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Endocrine
1
Dermatologic
1
Conditions
Precancerous Conditions
26
Neoplasms
8
Obesity-Related Malignant Neoplasm
7
Myelodysplastic Syndromes
5
Leukemia, Myeloid, Acute
5
Leukemia
5
Uterine Cervical Neoplasms
4
Preleukemia
4
Neoplasms by Histologic Type
4
Hematologic Diseases
4
Bone Marrow Diseases
4
Primary Myelofibrosis
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Myeloproliferative Disorders
3
Lymphoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia, Biphenotypic, Acute
3
Keratosis, Actinic
3
Immunoproliferative Disorders
3
Immune System Diseases
3
Head and Neck Neoplasms
3
Colorectal Neoplasms
3
Colonic Neoplasms
3
Advanced Malignant Neoplasm
3
Uterine Cervical Dysplasia
2
Thrombocythemia, Essential
2
Stomach Neoplasms
2
Skin Diseases
2
Neoplasms by Site
2
Myelodysplastic-Myeloproliferative Diseases
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hypersensitivity
×
Other neoplasm
×
1 year
×
Clear all
NCT01837693
2025-06-26
NTCC2
Azienda USL Reggio Emilia - IRCCS
Phase NA
Completed
41,127 enrolled